The UK Vaccine Minister Nadhim Zahawi has said he received a recommendations from the Joint Committee on Vaccination and Immunisation (JCVI) about whether to recommend vaccines for under-18s, BBC News reported on Monday.
Zahawi told BBC Breakfast he will make a statement to Parliament later, but he says the JCVI has recommended that children with medical conditions that make them vulnerable to COVID-19 should be vaccinated, along with those who live with clinically vulnerable people.
He also said the committee recommends that children close to their 18th birthday should have the vaccine.
However, the JCVI will be keeping under review whether or not to vaccinate healthy children aged 12 to 17.
Reportedly, the committee is concerned about some data suggesting there may be rare cases of myocarditis, an inflammation of the heart muscle, linked to the vaccine.
Merck reports positive Phase 2b results for tulisokibart in hidradenitis suppurativa
Genentech's fenebrutinib receives FDA priority review for multiple sclerosis
BRC Therapeutics participates in regulators' workshop advancing botanical drug development
Ascletis reports positive results from ASC50 clinical study for treatment of plaque psoriasis
XtalPi submits US FDA IND application for KQTD-126 in chronic intestinal pain
AbbVie secures EU approval for RINVOQ in polyarticular juvenile idiopathic arthritis
Altesa BioSciences presents positive vapendavir clinical data at ERS International Congress 2026
Kali Therapeutics' KT501 Investigational New Drug application cleared by US FDA
Teva reports positive Phase 2a data for TEV '408 in celiac disease
AbbVie seeks EMA approval for subcutaneous induction of risankizumab in Crohn's disease
AstraZeneca and Amgen report Tezspire met primary endpoints in Phase III EoE trial
Oxcia receives EMA orphan designation for OXC-201 in idiopathic pulmonary fibrosis
Graviton BioScience reports positive trial results for GV101 in chronic Graft versus Host Disease
Cellenkos' CK0803 granted US FDA Fast Track designation for ALS